Short Interest in Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) Declines By 20.0%

Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) saw a large decrease in short interest in September. As of September 30th, there was short interest totalling 255,300 shares, a decrease of 20.0% from the September 15th total of 319,200 shares. Based on an average daily trading volume, of 900 shares, the short-interest ratio is presently 283.7 days.

Kyowa Kirin Price Performance

OTCMKTS:KYKOF remained flat at $20.97 during mid-day trading on Tuesday. The firm has a 50 day simple moving average of $20.82 and a two-hundred day simple moving average of $18.60. Kyowa Kirin has a 12-month low of $15.78 and a 12-month high of $22.21.

About Kyowa Kirin

Kyowa Kirin Co, Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.